Mortality rate of patients with cystic fibrosis on the waiting list and within one year after lung transplantation: A survey of Italian CF centers

Beatrice Borchi, Marisol Barao Ocampo, Giuseppe Cimino, Giovanna Pizzamiglio, Silvia Bresci, Cesare Braggion

Research output: Contribution to journalArticle

Abstract

Background: Cystic Fibrosis (CF) Centers are involved in the decisions regarding the eligibility of CF patients with end-stage lung disease and timing for inclusion on waiting lists (WL) for lung transplantation (LT). There are currently no data on the mortality rates of Italian CF patients on WL and during the first year after LT and we aimed to assess these outcomes by surveying the CF Centers. Methods: A survey was sent to Italian CF Centers which were requested to report the age at which all CF subjects included on the WL between 2010 and 2014 were included on the list, admitted to either standard or urgent LT, or had died either while on the WL or within the first 3 and 12 months after LT. All outcomes were recorded by December 31, 2015. Results: Two hundred fifty-nine CF subjects were included on the WL during the 5-year study period. The mortality rate during the WL was 19.3% and was not associated with sex, age at inclusion on the WL or standard or urgent access to LT. 159 (61.4%) subjects underwent LT, 46 (28.9%) with urgent procedure. Deaths within the first 3 and 12 months after LT were significantly more prevalent in individuals who underwent urgent LT compared to those with standard LT (p < 0.01). Conclusions: The mortality of Italian CF patients, included in our survey, was about twice that reported by the National Transplant Center for all LT indications, including CF, during the same time period and despite the introduction of urgent LT. The latter was associated with an unfavorable early outcome compared to standard LT.

Original languageEnglish
Article number72
JournalItalian Journal of Pediatrics
Volume44
Issue number1
DOIs
Publication statusPublished - Jun 28 2018

Fingerprint

Waiting Lists
Lung Transplantation
Cystic Fibrosis
Mortality
Surveys and Questionnaires
Lung Diseases

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Mortality rate of patients with cystic fibrosis on the waiting list and within one year after lung transplantation : A survey of Italian CF centers. / Borchi, Beatrice; Barao Ocampo, Marisol; Cimino, Giuseppe; Pizzamiglio, Giovanna; Bresci, Silvia; Braggion, Cesare.

In: Italian Journal of Pediatrics, Vol. 44, No. 1, 72, 28.06.2018.

Research output: Contribution to journalArticle

@article{1184f90f9b754b3bb7eef889131fc2f0,
title = "Mortality rate of patients with cystic fibrosis on the waiting list and within one year after lung transplantation: A survey of Italian CF centers",
abstract = "Background: Cystic Fibrosis (CF) Centers are involved in the decisions regarding the eligibility of CF patients with end-stage lung disease and timing for inclusion on waiting lists (WL) for lung transplantation (LT). There are currently no data on the mortality rates of Italian CF patients on WL and during the first year after LT and we aimed to assess these outcomes by surveying the CF Centers. Methods: A survey was sent to Italian CF Centers which were requested to report the age at which all CF subjects included on the WL between 2010 and 2014 were included on the list, admitted to either standard or urgent LT, or had died either while on the WL or within the first 3 and 12 months after LT. All outcomes were recorded by December 31, 2015. Results: Two hundred fifty-nine CF subjects were included on the WL during the 5-year study period. The mortality rate during the WL was 19.3{\%} and was not associated with sex, age at inclusion on the WL or standard or urgent access to LT. 159 (61.4{\%}) subjects underwent LT, 46 (28.9{\%}) with urgent procedure. Deaths within the first 3 and 12 months after LT were significantly more prevalent in individuals who underwent urgent LT compared to those with standard LT (p < 0.01). Conclusions: The mortality of Italian CF patients, included in our survey, was about twice that reported by the National Transplant Center for all LT indications, including CF, during the same time period and despite the introduction of urgent LT. The latter was associated with an unfavorable early outcome compared to standard LT.",
author = "Beatrice Borchi and {Barao Ocampo}, Marisol and Giuseppe Cimino and Giovanna Pizzamiglio and Silvia Bresci and Cesare Braggion",
year = "2018",
month = "6",
day = "28",
doi = "10.1186/s13052-018-0512-y",
language = "English",
volume = "44",
journal = "Italian Journal of Pediatrics",
issn = "1720-8424",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Mortality rate of patients with cystic fibrosis on the waiting list and within one year after lung transplantation

T2 - A survey of Italian CF centers

AU - Borchi, Beatrice

AU - Barao Ocampo, Marisol

AU - Cimino, Giuseppe

AU - Pizzamiglio, Giovanna

AU - Bresci, Silvia

AU - Braggion, Cesare

PY - 2018/6/28

Y1 - 2018/6/28

N2 - Background: Cystic Fibrosis (CF) Centers are involved in the decisions regarding the eligibility of CF patients with end-stage lung disease and timing for inclusion on waiting lists (WL) for lung transplantation (LT). There are currently no data on the mortality rates of Italian CF patients on WL and during the first year after LT and we aimed to assess these outcomes by surveying the CF Centers. Methods: A survey was sent to Italian CF Centers which were requested to report the age at which all CF subjects included on the WL between 2010 and 2014 were included on the list, admitted to either standard or urgent LT, or had died either while on the WL or within the first 3 and 12 months after LT. All outcomes were recorded by December 31, 2015. Results: Two hundred fifty-nine CF subjects were included on the WL during the 5-year study period. The mortality rate during the WL was 19.3% and was not associated with sex, age at inclusion on the WL or standard or urgent access to LT. 159 (61.4%) subjects underwent LT, 46 (28.9%) with urgent procedure. Deaths within the first 3 and 12 months after LT were significantly more prevalent in individuals who underwent urgent LT compared to those with standard LT (p < 0.01). Conclusions: The mortality of Italian CF patients, included in our survey, was about twice that reported by the National Transplant Center for all LT indications, including CF, during the same time period and despite the introduction of urgent LT. The latter was associated with an unfavorable early outcome compared to standard LT.

AB - Background: Cystic Fibrosis (CF) Centers are involved in the decisions regarding the eligibility of CF patients with end-stage lung disease and timing for inclusion on waiting lists (WL) for lung transplantation (LT). There are currently no data on the mortality rates of Italian CF patients on WL and during the first year after LT and we aimed to assess these outcomes by surveying the CF Centers. Methods: A survey was sent to Italian CF Centers which were requested to report the age at which all CF subjects included on the WL between 2010 and 2014 were included on the list, admitted to either standard or urgent LT, or had died either while on the WL or within the first 3 and 12 months after LT. All outcomes were recorded by December 31, 2015. Results: Two hundred fifty-nine CF subjects were included on the WL during the 5-year study period. The mortality rate during the WL was 19.3% and was not associated with sex, age at inclusion on the WL or standard or urgent access to LT. 159 (61.4%) subjects underwent LT, 46 (28.9%) with urgent procedure. Deaths within the first 3 and 12 months after LT were significantly more prevalent in individuals who underwent urgent LT compared to those with standard LT (p < 0.01). Conclusions: The mortality of Italian CF patients, included in our survey, was about twice that reported by the National Transplant Center for all LT indications, including CF, during the same time period and despite the introduction of urgent LT. The latter was associated with an unfavorable early outcome compared to standard LT.

UR - http://www.scopus.com/inward/record.url?scp=85049203678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049203678&partnerID=8YFLogxK

U2 - 10.1186/s13052-018-0512-y

DO - 10.1186/s13052-018-0512-y

M3 - Article

AN - SCOPUS:85049203678

VL - 44

JO - Italian Journal of Pediatrics

JF - Italian Journal of Pediatrics

SN - 1720-8424

IS - 1

M1 - 72

ER -